1926-2016. COMANDATE FIDEL CASTRO. Por siempre y para siempre entre nosotros

       
Prev Next

Heberprot-P registered in 23 countries

06-09-2016 Hits:768

Heberprot-P registered in 23 countries

Ten years after receiving its health registration and approval to be used in the national health system, the medicine Heber¬prot-P has been used to treat over 55,000 Cuban patients nationwide, with positive results Ten years after receiving its health registration and approval to be used in the national health system, the medicine Heber­prot-P has been used to treat over 55,000 Cuban patients nationwide, with positive results. Developed by a team of experts led by Dr. Jorge Berlanga Acosta from the Center for Genetic Engineering and Biotechnology (CIGB), Heber­prot-P is an injectable medication used to treat advanced foot ulcers in diabetic patients by accelerating the healing process, thus reducing the risk of amputation in over 78% of cases. The only one of its kind in the world, the product received the Gold Medal awarded by the World Intellectual Property Organization (WIPO) and offers a novel therapeutic solution to a condition which previously lacked effective...

Cuba registers new skin cancer medicine

06-09-2016 Hits:408

Cuba registers new skin cancer medicine

Cuba has registered a new skin cancer medicine called “Heberferon” developed by the island’s Genetic Engineering and Biotechnology Center (CIGB) After 20 years of research and clinical trials, Cuba’s Havana-based Genetic Engineering and Biotechnology Center (CIGB) has developed a new medicine called “Heberferon.” BiologistIraldo Bello, who participated in the process, described the drug which combines interferón “Alfa” and interferón “Gamma” through the use of recombinant technology at the CIGB - as “unique” in the world.  The injectable medication cures or reduces the size of malignant skin tumors and can prevent scaring from surgery in areas difficult to operate on such as the face, noted the specialist.  Bello also explained that Cuba has a high rate of skin cancer, which is usually caused by excessive exposure to the sun. CIGB production plants have already manufactured over 10,000 vials of the new medicine, which continues to be developed with the aim of treating other types of cancer....

Want to Improve the Health of Millions of Americans? Lift the Embargo on Cuba

06-08-2015 Hits:2013

Want to Improve the Health of Millions of Americans? Lift the Embargo on Cuba

By reopening embassies, removing Cuba from the “terror list” and making it a bit easier for Americans to travel there, President Barack Obama’s White House has taken initial steps to put an end to a policy that has adversely affected the health of the American people for over half a century. The Senate Appropriation Committee’s action last week to even further ease restrictions on travel to Cuba by U.S. citizens and relax some provisions of the economic embargo, is welcome for a variety of reasons, but perhaps most urgently for the health of citizens in both countries. Forty years ago, when Jimmy Carter lifted the then-total ban on Americans traveling to Cuba, it became very clear to me as an adviser on health policy to the president, that no element of our two societies would benefit more from the free exchange of ideas than the health of our two peoples.  The announcement...

Cuba’s flag flies in Washington

06-08-2015 Hits:2019

Cuba’s flag flies in Washington

Washington, D.C — In a ceremony attended by some 500 invited guests on July 20, the Cuban flag was raised over the Cuban Embassy in Washington, D.C., for the first time since 1961, when U.S. imperialism broke relations between the two countries. Other supporters successfully fought back right-wing forces who tried to disrupt the event. Bruno Rodríguez Parrilla, foreign affairs minister of Cuba, told those gathered: “The flag that we revere … is the same that was hauled down here 54 years ago, which was zealously kept in Florida by a family of liberators and later on by the museum of our eastern city of Las Tunas, as a sort of premonition that this day would certainly come. “Flying once again in this place is the lone-star flag which embodies the generous blood that was shed, the sacrifices made and the struggle waged for more than 100 years by our people for their...

As Cuba-US Relations Thaw, Potential Medical Advances Grow

13-07-2015 Hits:2283

As Cuba-US Relations Thaw, Potential Medical Advances Grow

Recent US steps toward normalizing relations with Cuba after 5 decades may open doors in both countries to medical advances. In December 2014, President Obama reestablished diplomatic relations and eased travel restrictions. In April of this year, Congress removed Cuba from its terror list, and this month, the two countries are expected to resume diplomatic relations and reopen embassies in both countries. Mark Rasenick, PhD, professor of physiology, biophysics, and psychology and director of the biomedical neuroscience training program in the University of Illinois at Chicago College of Medicine, travels to Cuba at least once a year and has testified before Congress on medical partnership possibilities. He told Medscape Medical News that some collaborations will be seen very soon, but new treatments and products will be available only if and when the trade embargo is lifted. One area in which Cuba can contribute expertise is brain mapping, Dr Rasenick said. Because widespread magnetic resonance...

Cuban Parliamentarian Supports Strengthening Russia-Cuba Cooperation

08-07-2015 Hits:2008

Cuban Parliamentarian Supports Strengthening Russia-Cuba Cooperation

Moscow, Jul 7 (Prensa Latina) Cuban parliamentarian and director of the National Center for Sexual Education of Cuba Mariela Castro Espin called today for strengthening cooperation between Cuba and Russia on health, during a meeting with Russian senators. Castro Espin said that the implementation of a joint project for the use, production and technological exchange related to the Cuban drug Heberprot could mean for Russia reduced costs valued at millions of dollars. In addition, she said that a comprehensive program regarding this subject guarantees an increase in life expectancy and quality of life of patients with diabetic foot disease, as well as reducing costs by Russian health system. Castro Espin reiterated that Cuba and Russia are united by historical ties of friendship, so that the joint implementation of the health program would be a new opportunity for strengthen them. For her part, counselor of the Cuban Embassy Natacha...

Type 11 diabetes cases expected to rise by 200mn globally over next two decades

24-03-2015 Hits:5640

Type 11 diabetes cases expected to rise by 200mn globally over next two decades

Diabetes is the catastrophe of the 21st century, remarked Sir Michael Hirst, the visiting President of the International Diabetes Federation (IDF) headquartered in Brussels, Belgium. This debilitating disease is a challenge to the world, to Sri Lanka and to every other country, he underscored. "No longer are those afflicted old people, even many teenagers are now diabetic". With a surge in Type 11 diabetes, the number is expected to rise by 200 million globally over the next 20 years, Sir Michael said in an interview with The Sunday Island on the sidelines of the recent launch of Heberprot-P, an innovative injectable drug in the treatment and cure of advanced diabetic foot ulcers, at the Ramada Hotel in Colombo. The majority four-fifth of these cases over the next two decades will be in the developing world, impacting people of working age. Diabetes is not just a health issue, but an economic development issue as...

Paris-based biotech ABIVAX launches pivotal clinical study on hep B candidate in Asia

06-03-2015 Hits:2686

Paris-based biotech ABIVAX launches pivotal clinical study on hep B candidate in Asia

SINGAPORE--Paris-based clinical biotech ABIVAX said it has recruited its first patient for an Asia Pacific-based pivotal Phase IIb-III clinical trial of a potential vaccine therapy of chronic hepatitis B via a controlling viral load for a much longer period of time when compared to current options. The first patient in New Zealand is part of a study to see if the candidate, ABX203, can provide better treatment for chronic hepatitis B. Formulated as a solution for nasal sprays and subcutaneous injections, ABX203 is a therapeutic vaccine designed to induce immune responses similar to those occurring in patients with a self-resolving acute HBV infection. "We are confident that ABX203, our therapeutic vaccine against chronic hepatitis B, could be a major progress in the treatment of patients with this devastating disease," Hartmut Ehrlich, the CEO of ABIVAX, said in a press statement. ABIVAX is expected to file for marketing approval of ABX203 in certain...

As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Remains Off-Limits

16-01-2015 Hits:2811

As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Remains Off-Limits

HAVANA – President Obama’s efforts to renew relations with Cuba may soon allow Americans to visit this island’s pristine beaches and start lugging home shopping bags filled with long-coveted cigars and rum. But for frustrated American physicians battling to save the feet and legs of tens of thousands of diabetic patients, it may be a long wait before a much-heralded limb-saving Cuban drug can legally make the 90-mile trip to U.S. shores. Because of the Cold War-spawned economic blockade against what Washington has long considered the Communist threat in the Caribbean, the developer of the medication, the Center for Genetic Engineering and Biotechnology in Havana, is forbidden to bring a nine-year-old drug, called Heberprot-P, to the U.S. for clinical trials and use. “I don’t know what’s going to happen, but I do know that it may be that American legs are being lost while Cuban legs are being saved because Washington agencies...

Heberprot-P benefits more than 31,000 Cubans

23-09-2014 Hits:6082

Heberprot-P benefits more than 31,000 Cubans

Cuba has reduced the risk of amputation caused by ulcers in diabetics by more than 78% thanks to the implementation of a comprehensive program across all provinces, directed toward treating patients suffering from the problem, including through the use of Heberprot-P. Developed by specialists from the Cuban Center for Genetic Engineering and Biotechnology(CIBG), in collaboration with other entities, Heberprot-P is the only drug worldwide, capable of enhancing the healing of such complex lesions and which has benefited more than 31,000Cubans. In addition, for three consecutive years the diabetes mortality rate in the country has continued to decrease, while 84% of suffers reach the same life expectancy as non-diabetic Cubans (around 78 years). These remarkable results will be presented at the International Congress on the Control of Diabetes, which will be take place in Varadero from December 10-12. According to Mailyn Palmero Molina, member of the event organizing committee, confirmed to attend is Mr. Michael...

Vinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo Slider

Parlamentarios rusos y cubanos elaboran nuevas colaboraciones

Heberprot-P. A safe and effective treatment

Aniversario 30

 

 

Redes Sociales

 

Próximo Evento

Other Areas

Spot HPH2012

Visit

2542234
Today
Yesterday
Thiis Week
Last Week
This Month
Last Month
All
1045
1961
9484
2518713
3006
61370
2542234